Abstract:Background The novel coronavirus disease (COVID-19) has been declared a global pandemic, with the cumulative number of confirmed cases and deaths exceeding 150 million and 3 million, respectively. Here, we examined the dynamic changes in the immune and clinical features of patients with COVID-19. Methods Clinical data of 98 patients with confirmed COVID-19 diagnosis were acquired from electronic medical records and curated. The data were analyzed based on the stage of the admission, deterioration, and convalescence, which included age, sex, severity, disease stages, biochemical indicators, immune cells, inflammatory cytokines, and immunoglobulins. Additionally, temporal changes in the immune response in patients undergoing continuous renal replacement therapy (CRRT) were also examined. Results Compared to mild stage patients, severe stage patients with COVID-19 exhibited a significant reduction in lymphocyte [23.10 (17.58–33.55) vs. 4.80 (2.95–6.50), P<0.001], monocyte [8.65 (7.28–10.00) vs. 3.45 (2.53–4.58), P<0.001], and NK cell levels [244.00 (150.50–335.00) vs. 59.00 (40.00–101.00), P<0.001] but showed elevated levels of neutrophils [64.90 (56.30–73.70) vs. 90.95 (87.60–93.68), P<0.001], inflammatory cytokines [Interleukin-10, 3.05 (1.37–3.86) vs. 5.94 (3.84–8.35), P=0.001; and tumor necrosis factor-α, 11.50 (6.55–26.45) vs. 12.96 (12.22–36.80), P=0.029], which improved during convalescence. Besides, the number of immune cells—T lymphocytes, B lymphocytes, helper T cells, suppressor T cells, NK cells, and monocytes, except neutrophils—slowly increased in critically ill patients receiving CRRT from 0 to 3 weeks. Conclusions Our results indicate that the surveillance of immune cells may contribute to monitoring COVID-19 disease progression, and CRRT is a potential therapeutic strategy to regulate the immune balance in critically ill patients.

IMMUNOHISTOCHEMICAL OBSERVATION OF IMMUNE CELLS IN THE KIDNEY OF PATIENTS WITH SARS

[Immune Activation in AIDS Related Kaposi's Sarcoma].

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

The spleen as a target in severe acute respiratory syndrome.

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

Expression of CD34,VEGF and ICAM-1 in lungs of severe acute respiratory syndrome

Measurement of the T Lymphocyte Subsets and the Th1/Th2 Cytokines in Patients with Severe Acute Respiratory Syndrome

Study on the Relationship Between Radiological Presence and Immune Indies in Patients with SARS

[Expression of SARS-CoV in Various Types of Cells in Lung Tissues].

THE EXPRESSION AND SIGNIFICANCE OF CYTOKINES IN LUNG TISSUE FROM SEVERE SARS PATIENTS

Early effect of SARS-COV-2 on renal tubule: a pilot study

Detection of Autoimmune Parameter of SARS Patients

[Immunological Characteristics of 1291 Cases of Severe Acute Respiratory Syndrome in Beijing].

Dynamic Changes in IgG and IgM Antibodies As Clinical Indicators During Recovery Stage in Patients with Severe Acute Respiratory Syndrome

[Prospective Clinical Study on Serum Immunity in IgG-antibodies Positive Patients Convalescent from Severe Acute Respiratory Syndrome].

Apoptosis Related Proteins Expressions of T Lymphocyte in SARS Convalescent Patients

Study on the Response of Specific Antibodies Against SARS-CoV in Patients Infected with SARS

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome

[Dynamics of Peripheral Blood B Lymphocytes and Natural Killer Cells in Patients with Severe Acute Respiratory Syndrome].